扳机前雌二醇下降与辅助生殖技术结局的关联
该回顾性队列研究纳入2010至2021年美国多中心6945个拮抗剂方案自体取卵周期,比较扳机前4天血清雌二醇下降与持续上升者的结局。校正抗苗勒管激素和女性年龄后,单次或2-4次下降者的可用囊胚数及活产率与持续上升组无统计学差异。
要点
- 扳机前4天血清雌二醇下降不损害卵母细胞质量。
- 单次下降组可用囊胚数平均比值为1.04(95%CI 0.97-1.10)。
- 活产率持续上升组41.1%,单次下降组36.8%,2-4次下降组42.1%。
核心结论
- 扳机前4天血清雌二醇下降不损害卵母细胞质量,其结局与持续上升者相当。
研究设计与样本
- 回顾性队列研究,纳入2010至2021年美国多中心6945个拮抗剂方案自体取卵周期。
主要发现
- 持续上升组5653周期,单次下降组1103周期,2-4次下降组189周期。
- 校正抗苗勒管激素和女性年龄后,可用囊胚数单次下降组平均比值1.04(95%CI 0.97-1.10),2-4次下降组0.98(95%CI 0.85-1.14)。
- 活产率持续上升组41.1%,单次下降组36.8%(风险比0.91,95%CI 0.81-1.02),2-4次下降组42.1%(风险比0.98,95%CI 0.74-1.28)。
- 所有次要结局包括活产均无统计学差异。
关键数值与推荐
- 暴露定义为扳机前4天任一天血清雌二醇下降至少1 pg/mL。
- 主要结局为可用囊胚数,即新鲜移植囊胚数与剩余冷冻囊胚数之和。
临床怎么用
- 扳机前血清雌二醇下降不应作为取消周期或改变扳机决策的依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study whether a decline in serum estradiol level in the days leading up to the ovulatory trigger in gonadotropin-releasing hormone antagonist ovarian stimulation cycles impacts cycle outcomes. DESIGN: Retrospective cohort study. SUBJECTS: Patients undergoing autologous retrieval cycles using a gonadotropin-releasing hormone antagonist protocol between 2010 and 2021 at a multicenter infertility practice network in the United States. Patients were excluded if an estradiol level was not measured on the 4 days before the ovulatory trigger or if they had conventional insemination. EXPOSURE: Patients with a documented decrease of at least 1 pg/mL in serum estradiol on any of the 4 days before ovulatory trigger. The referent group experienced a consistent rise in serum estradiol each day before the trigger. MAIN OUTCOME MEASURES: The primary outcome was the number of usable blastocysts, defined as the sum of blastocysts used for fresh transfer (if any) and the remaining cryopreserved blastocysts. Secondary outcomes included oocyte maturity, fertilization, ≥1 usable blastocyst, positive human chorionic gonadotropin, biochemical pregnancy, spontaneous abortion, clinical pregnancy, and live birth. RESULTS: A total of 6,945 cycles met the inclusion criteria. Among this cohort, 5,653 demonstrated a consistent rise in serum estradiol, 1,103 cycles experienced one drop, and 189 cycles experienced 2-4 drops in estradiol during the 4 days preceding the ovulatory trigger. After adjusting for antimüllerian hormone and female age, there was no difference in the average number of usable blastocysts between the referent group (4.9 ± 4.0) and cycles with a single drop in estradiol (5.2 ± 4.8) (mean ratio 1.04, 95% confidence interval [CI] 0.97-1.10) and those with 2-4 drops in estradiol (mean ratio 0.98, 95% CI 0.85-1.14). There were no statistical differences in any of the secondary outcomes, including live birth. Live birth was observed at 41.1% for the consistent rise group, 36.8% for the one-drop group (risk ratio 0.91, 95% CI 0.81-1.02), and 42.1% for the 2-4 drops group (risk ratio 0.98, 95% CI 0.74-1.28). CONCLUSION: The findings underscore that a decline in serum estradiol in the 4 days before the ovulatory trigger does not compromise oocyte quality. Patients with an estradiol decline preceding oocyte retrieval had comparable outcomes to those with a continued rise in estradiol.
引用
- Lindner P, Flannagan K, Echague C, et al. Association between serum estradiol level decline in the days preceding ovulatory trigger and assisted reproductive technology outcomes. Fertil Steril. 2026. PMID: 41771339. doi:10.1016/j.fertnstert.2026.02.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。